Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster drugs Ozempic and Wegovy from the drug shortage list, rejecting a challenge ...

Eli Lilly is buying Verve Therapeutics, developer of gene-editing treatments for cardiovascular disease, for $1 billion plus ...

Discover the latest business news including rising gas prices, Zepbound shipments, At Home bankruptcy, and the Federal Reserve meeting.

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

The clinical trial underscores Innovent’s ambition to deliver innovative obesity treatment to patients across Asia.

Lilly’s announcement Tuesday focused on single-dose vials for people paying out of pocket for the two lowest doses of Zepbound, priced at $399 and $549, and did not mention the savings-card ...

Dr. Xu Chen presented the results of a dose-escalation phase I trial evaluating intravesical disitamab vedotin (RC48) for patients with HER-2 expressing high-risk, non-muscle invasive bladder cancer ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in children with status asthmaticus. Design Retrospective analysis of inpatient medical records and ...